Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:1600-1606

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daoud, E. G.
Right arrow Articles by Morady, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daoud, E. G.
Right arrow Articles by Morady, F.

(Circulation. 1996;94:1600-1606.)
© 1996 American Heart Association, Inc.


Articles

Effect of Atrial Fibrillation on Atrial Refractoriness in Humans

Emile G. Daoud, MD; Frank Bogun, MD; Rajiva Goyal, MD; Mark Harvey, MD; K. Ching Man, DO; S. Adam Strickberger, MD; Fred Morady, MD

the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor.

Correspondence to Fred Morady, MD, University of Michigan Hospital, Division of Cardiology, B1-F245, 1500 E Medical Center Dr, Ann Arbor, MI 48109-0022.

BackgroundThe acute effect of atrial fibrillation (AF) on the atrial effective refractory period (ERP) in humans is unknown.

Methods and Results In 20 patients without structural heart disease, the atrial ERP was measured before and after pacing-induced AF at drive cycle lengths of 350 and 500 ms. Immediately after spontaneous AF conversion, the post-AF ERP was measured. The pre-AF ERPs at 350 and 500 ms were 206±23 and 216±17 ms, respectively. The time to spontaneous conversion of AF was 7.3±1.9 minutes. The first post-AF ERPs at drive cycle lengths of 350 and 500 ms were 175±30 ms (P<.0001 versus pre-AF) and 191±30 ms (P<.0001 versus pre-AF), respectively. The post-AF ERP returned to the pre-AF ERP value after a mean of 8.4±0.3 minutes. In 15 patients, during the determination of the post-AF ERP, secondary episodes of AF lasting 1±1.5 minutes were reinduced 6±3 times per patient. There was a significant inverse logarithmic relationship between the time to reinduction of AF and the duration of secondary episodes of AF (P<.0001, r=.5).

Conclusions In humans, several minutes of induced AF is sufficient to shorten the ERP for up to {approx}8 minutes. The temporal recovery of the ERP is reflected in progressively shorter episodes of reinduced AF. These data imply that AF transiently shortens the atrial wavelength and suggest a mechanism by which AF may perpetuate itself.


Key Words: fibrillation • atrium • electrophysiology




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Etzion, M. Mor, A. Shalev, S. Dror, O. Etzion, A. Dagan, O. Beharier, A. Moran, and A. Katz
New insights into the atrial electrophysiology of rodents using a novel modality: the miniature-bipolar hook electrode
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1460 - H1469.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Rostock, D. Steven, B. Lutomsky, H. Servatius, I. Drewitz, H. Klemm, K. Mullerleile, R. Ventura, T. Meinertz, and S. Willems
Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans.
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2153 - 2160.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. P. Knight
The pulmonary veins speedy recoveries and early discharges.
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2161 - 2162.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. P. Regan, L. Kiss, G. L. Stump, C. J. McIntyre, D. C. Beshore, N. J. Liverton, C. J. Dinsmore, and J. J. Lynch Jr.
Atrial Antifibrillatory Effects of Structurally Distinct IKur Blockers 3-[(Dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-Phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in Dogs with Underlying Heart Failure
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 322 - 330.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
K. A. Hafid, H. C. Xin, W. Xi, Z. Q. Yan, and Y. Bo
Difference between electrical remodelling after pulmonary veins and right atrium appendage pacing
Europace, July 13, 2007; (2007) eum108v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. K Nergardh, M. Rosenqvist, R. Nordlander, and M. Frick
Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study
Eur. Heart J., June 1, 2007; 28(11): 1351 - 1357.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. L. Stump, A. A. Wallace, C. P. Regan, and J. J. Lynch Jr.
In Vivo Antiarrhythmic and Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1362 - 1367.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Shah, F. G. Akar, and G. F. Tomaselli
Molecular Basis of Arrhythmias
Circulation, October 18, 2005; 112(16): 2517 - 2529.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A. Sosunov, E. P. Anyukhovsky, D. Hefer, T. S. Rosen, P. Danilo Jr., M. J. Janse, and M. R. Rosen
Region-specific, pacing-induced changes in repolarization in rabbit atrium: An example of sensitivity to the rare
Cardiovasc Res, August 1, 2005; 67(2): 274 - 282.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. Scherlag, W. Yamanashi, U. Patel, R. Lazzara, and W. M. Jackman
Autonomically Induced Conversion of Pulmonary Vein Focal Firing Into Atrial Fibrillation
J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1878 - 1886.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
E. G. Manios, E. M. Kallergis, E. M. Kanoupakis, H. E. Mavrakis, H. K. Mouloudi, N. K. Klapsinos, and P. E. Vardas
Effects of successful cardioversion of persistent atrial fibrillation on right ventricular refractoriness and repolarization
Europace, January 1, 2005; 7(1): 34 - 39.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
D. Vollmann, E. Kollet, L. Lüthje, S. Busse, and C. Unterberg
Comparison of immediate and delayed automatic antitachycardia pacing for the termination of atrial tachyarrhythmias
Europace, January 1, 2005; 7(3): 248 - 254.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Sticherling, S. Behrens, W. Kamke, A. Stahn, and M. Zabel
Comparison of acute and long-term effects of single-dose amiodarone and verapamil for the treatment of immediate recurrences of atrial fibrillation after transthoracic cardioversion
Europace, January 1, 2005; 7(6): 546 - 553.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Deroubaix, T. Folliguet, C. Rucker-Martin, S. Dinanian, C. Boixel, P. Validire, P. Daniel, A. Capderou, and S. N. Hatem
Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1918 - 1926.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C-J A Lindholm, O Fredholm, S-J Moller, N Edvardsson, T Kronvall, T Pettersson, V Firsovaite, A Roijer, C J Meurling, P G Platonov, et al.
Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil
Heart, May 1, 2004; 90(5): 534 - 538.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Todd, S. P. Fynn, A. P. Walden, W. J. Hobbs, S. Arya, and C. J. Garratt
Repetitive 4-Week Periods of Atrial Electrical Remodeling Promote Stability of Atrial Fibrillation: Time Course of a Second Factor Involved in the Self-Perpetuation of Atrial Fibrillation
Circulation, March 23, 2004; 109(11): 1434 - 1439.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Spurrell, K. Kamalvand, M. Higson, and N. Sulke
Temporal changes in atrial refractoriness following DC cardioversion of persistent atrial fibrillation in man
Europace, January 1, 2004; 6(3): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. De Simone, M. De Pasquale, C. De Matteis, M. Canciello, M. Manzo, L. Sabino, F. Alfano, M. Di Mauro, A. Campana, G. De Fabrizio, et al.
VErapamil Plus Antiarrhythmic drugs Reduce Atrial Fibrillation recurrences after an electrical cardioversion (VEPARAF Study)
Eur. Heart J., August 1, 2003; 24(15): 1425 - 1429.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. F. Bosch, C. R. Scherer, N. Rub, S. Wohrl, K. Steinmeyer, H. Haase, A. E. Busch, L. Seipel, and V. Kuhlkamp
Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces ICa,L and Ito in rapid atrial pacing in rabbits
J. Am. Coll. Cardiol., March 5, 2003; 41(5): 858 - 869.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S K S Lairikyengbam, M H Anderson, and A G Davies
Present treatment options for atrial fibrillation
Postgrad. Med. J., February 1, 2003; 79(928): 67 - 73.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
I. Savelieva and A. John Camm
Atrial fibrillation and heart failure: natural history and pharmacological treatment
Europace, January 1, 2003; 5(s1): S5 - S19.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H.-F. Tse and C.-P. Lau
Electrophysiologic actions of dl-sotalolin patients with persistent atrial fibrillation
J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2150 - 2155.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Jais, M. Hocini, L. Macle, K.-J. Choi, I. Deisenhofer, R. Weerasooriya, D. C. Shah, S. Garrigue, F. Raybaud, C. Scavee, et al.
Distinctive Electrophysiological Properties of Pulmonary Veins in Patients With Atrial Fibrillation
Circulation, November 5, 2002; 106(19): 2479 - 2485.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. P. Fynn and C. J. Garratt
The effectiveness of serial cardioversion therapy for recurrence of atrial fibrillation
Eur. Heart J., October 1, 2002; 23(19): 1487 - 1489.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
C. Sticherling, M. Ozaydin, H. Tada, H. Oral, F. Pelosi, B. P. Knight, S. A. Strickberger, and F. Morady
Comparison of Verapamil and Ibutilide for the Suppression of Immediate Recurrences of Atrial Fibrillation after Transthoracic Cardioversion
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 155 - 160.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
D. Schwartzman, S. K. Musley, C. Swerdlow, R. H. Hoyt, and E. N. Warman
early recurrence of atrial fibrillation after ambulatory shock conversion
J. Am. Coll. Cardiol., July 3, 2002; 40(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Goette, M. Arndt, C. Rocken, T. Staack, R. Bechtloff, D. Reinhold, C. Huth, S. Ansorge, H. U. Klein, and U. Lendeckel
Calpains and cytokines in fibrillating human atria
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H264 - H272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Xie, Z. Qu, A. Garfinkel, and J. N. Weiss
Electrical refractory period restitution and spiral wave reentry in simulated cardiac tissue
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H448 - H460.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Biffi, G Boriani, M Bartolotti, L Bacchi Reggiani, R Zannoli, and A Branzi
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters
Heart, May 1, 2002; 87(5): 443 - 448.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Allessie, J. Ausma, and U. Schotten
Electrical, contractile and structural remodeling during atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 230 - 246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. F Bosch and S. Nattel
Cellular electrophysiology of atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 259 - 269.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Korte, M. Niehaus, G. Borchert, and J. Tebbenjohanns
Significant prolongation of atrial monophasic action potential duration: short-term reverse electrophysiological changes after internal cardioversion of atrial fibrillation
Cardiovasc Res, March 1, 2002; 53(4): 944 - 951.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. J Workman, K. A Kane, and A. C Rankin
The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation
Cardiovasc Res, November 1, 2001; 52(2): 226 - 235.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. M. Rahme, G. Ungab, M. Wadhwa, F. Al-Kandari, B. Yao, A. Gupta, K. Lee, H.-Y. Kim, and G. K. Feld
Electrophysiologic and Antiarrhythmic Effects of the New Class III Antiarrhythmic Drug KCB-328 in Experimental Canine Atrial Flutter
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2001; 6(3): 297 - 306.
[Abstract] [PDF]


Home page
Eur Heart JHome page
P.E. Vardas, E.G. Manios, E.M. Kanoupakis, D.N. Dermitzaki, H.E. Mavrakis, and E.M. Kallergis
Atrial defibrillation threshold in humans minutes after atrial fibrillation induction. 'a stitch in time saves nine'
Eur. Heart J., September 1, 2001; 22(17): 1613 - 1617.
[Abstract] [PDF]


Home page
HeartHome page
E. BERTAGLIA, D. D'ESTE, A. ZANOCCO, F. ZERBO, and P. PASCOTTO
Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study
Heart, May 1, 2001; 85(5): 578 - 580.
[Full Text]


Home page
Eur Heart JHome page
C Pandozi and M Santini
Update on atrial remodelling owing to rate. Does atrial fibrillation always 'beget' atrial fibrillation?
Eur. Heart J., April 1, 2001; 22(7): 541 - 553.
[PDF]


Home page
Cardiovasc ResHome page
H. Sun, D. Chartier, N. Leblanc, and S. Nattel
Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes
Cardiovasc Res, March 1, 2001; 49(4): 751 - 761.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Pandozi, L. Bianconi, L. Calo, A. Castro, F. Lamberti, M. C. Scianaro, G. Gentilucci, and M. Santini
Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2234 - 2241.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Sticherling, H. Oral, J. Horrocks, S. P. Chough, R. L. Baker, M. H. Kim, K. Wasmer, F. Pelosi, B. P. Knight, G. F. Michaud, et al.
Effects of Digoxin on Acute, Atrial Fibrillation-Induced Changes in Atrial Refractoriness
Circulation, November 14, 2000; 102(20): 2503 - 2508.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-J. Chen, S.-A. Chen, M.-S. Chang, and C.-I Lin
Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation
Cardiovasc Res, November 1, 2000; 48(2): 265 - 273.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. B. Sparks, S. Jayaprakash, J. K. Vohra, and J. M. Kalman
Electrical Remodeling of the Atria Associated With Paroxysmal and Chronic Atrial Flutter
Circulation, October 10, 2000; 102(15): 1807 - 1813.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. J. Sih, D. P. Zipes, E. J. Berbari, D. E. Adams, and J. E. Olgin
Differences in organization between acute and chronic atrial fibrillation in dogs
J. Am. Coll. Cardiol., September 1, 2000; 36(3): 924 - 931.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Bollmann
Quantification of electrical remodeling in human atrial fibrillation
Cardiovasc Res, August 1, 2000; 47(2): 207 - 209.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. G. Manios, E. M. Kanoupakis, G. I. Chlouverakis, M. D. Kaleboubas, H. E. Mavrakis, and P. E. Vardas
Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence
Cardiovasc Res, August 1, 2000; 47(2): 244 - 253.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Yamada, J. Hayano, S. Sakata, A. Okada, S. Mukai, N. Ohte, and G. Kimura
Reduced Ventricular Response Irregularity Is Associated With Increased Mortality in Patients With Chronic Atrial Fibrillation
Circulation, July 18, 2000; 102(3): 300 - 306.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Kuhlkamp, A. Schirdewan, K. Stangl, M. Homberg, M. Ploch, and O. A. Beck
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Nakashima, K. Kumagai, H. Urata, N. Gondo, M. Ideishi, and K. Arakawa
Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation
Circulation, June 6, 2000; 101(22): 2612 - 2617.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. M.W. van der Velden, J. Ausma, M. B. Rook, A. J.C.G.M. Hellemons, T. A.A.B. van Veen, M. A. Allessie, and H. J. Jongsma
Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat
Cardiovasc Res, June 1, 2000; 46(3): 476 - 486.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Scheinman
Mechanisms of atrial fibrillation: is a cure at hand?
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1687 - 1692.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Niwano, Y Kitano, M Moriguchi, and T Izumi
Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome
Heart, May 1, 2000; 83(5): 8e - 8.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Yamashita, Y. Murakawa, N. Hayami, E.-i. Fukui, Y. Kasaoka, M. Inoue, and M. Omata
Short-Term Effects of Rapid Pacing on mRNA Level of Voltage-Dependent K+ Channels in Rat Atrium : Electrical Remodeling in Paroxysmal Atrial Tachycardia
Circulation, April 25, 2000; 101(16): 2007 - 2014.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. V. Jayachandran, D. P. Zipes, J. Weksler, and J. E. Olgin
Role of the Na+/H+ Exchanger in Short-Term Atrial Electrophysiological Remodeling
Circulation, April 18, 2000; 101(15): 1861 - 1866.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. J. C. Hobbs, S. Fynn, D. M. Todd, P. Wolfson, M. Galloway, and C. J. Garratt
Reversal of Atrial Electrical Remodeling After Cardioversion of Persistent Atrial Fibrillation in Humans
Circulation, March 14, 2000; 101(10): 1145 - 1151.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. V. Jayachandran, H. J. Sih, W. Winkle, D. P. Zipes, G. D. Hutchins, and J. E. Olgin
Atrial Fibrillation Produced by Prolonged Rapid Atrial Pacing Is Associated With Heterogeneous Changes in Atrial Sympathetic Innervation
Circulation, March 14, 2000; 101(10): 1185 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. W. Hogue Jr and M. L. Hyder
Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment
Ann. Thorac. Surg., January 1, 2000; 69(1): 300 - 306.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Dorian and D. Newman
Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview
Europace, January 1, 2000; 2(4): 277 - 285.
[Abstract] [PDF]


Home page
CirculationHome page
S. Fareh, A. Benardeau, B. Thibault, and S. Nattel
The T-Type Ca2+ Channel Blocker Mibefradil Prevents the Development of a Substrate for Atrial Fibrillation by Tachycardia-Induced Atrial Remodeling in Dogs
Circulation, November 23, 1999; 100(21): 2191 - 2197.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. M. Rahme, B. Cotter, E. Leistad, M. K. Wadhwa, R. Mohabir, A. P. D. W. Ford, R. M. Eglen, and G. K. Feld
Electrophysiological and Antiarrhythmic Effects of the Atrial Selective 5-HT4 Receptor Antagonist RS-100302 in Experimental Atrial Flutter and Fibrillation
Circulation, November 9, 1999; 100(19): 2010 - 2017.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. B. Sparks, H. G. Mond, J. K. Vohra, S. Jayaprakash, and J. M. Kalman
Electrical Remodeling of the Atria Following Loss of Atrioventricular Synchrony : A Long-Term Study in Humans
Circulation, November 2, 1999; 100(18): 1894 - 1900.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Bollmann, K. Sonne, H.-D. Esperer, I. Toepffer, J. J Langberg, and H. U Klein
Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG
Cardiovasc Res, October 1, 1999; 44(1): 60 - 66.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. F. Bosch, X. Zeng, J. B. Grammer, K. Popovic, C. Mewis, and V. Kuhlkamp
Ionic mechanisms of electrical remodeling in human atrial fibrillation
Cardiovasc Res, October 1, 1999; 44(1): 121 - 131.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. De Simone, G. Stabile, D. F. Vitale, P. Turco, M. Di Stasio, F. Petrazzuoli, M. Gasparini, C. De Matteis, R. Rotunno, and T. Di Napoli
Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 810 - 814.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H-F Tse, C-P Lau, and G M Ayers
Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol
Heart, September 1, 1999; 82(3): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L.-M. Rodriguez, C. Timmermans, and H. J. J. Wellens
Are Electrophysiological Changes Induced by Longer Lasting Atrial Fibrillation Reversible? : Observations Using the Atrial Defibrillator
Circulation, July 13, 1999; 100(2): 113 - 116.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Kamalvand, K. Tan, G. Lloyd, J. Gill, C. Bucknall, and N. Sulke
Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man
Eur. Heart J., June 2, 1999; 20(12): 888 - 895.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
S. Nattel
Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation
Cardiovasc Res, May 1, 1999; 42(2): 298 - 308.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W.-C. Yu, S.-H. Lee, C.-T. Tai, C.-F. Tsai, M.-H. Hsieh, C.-C. Chen, Y.-A. Ding, M.-S. Chang, and S.-A. Chen
Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man
Cardiovasc Res, May 1, 1999; 42(2): 470 - 476.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L.-P. Lai, M.-J. Su, J.-L. Lin, F.-Y. Lin, C.-H. Tsai, Y.-S. Chen, S. K. S. Huang, Y.-Z. Tseng, and W.-P. Lien
Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling
J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1231 - 1237.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S.-H. Lee, F.-Y. Lin, W.-C. Yu, J.-J. Cheng, P. Kuan, C.-R. Hung, M.-S. Chang, and S.-A. Chen
Regional Differences in the Recovery Course of Tachycardia-Induced Changes of Atrial Electrophysiological Properties
Circulation, March 9, 1999; 99(9): 1255 - 1264.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. B. Sparks, S. Jayaprakash, H. G. Mond, J. K. Vohra, L. E. Grigg, and J. M. Kalman
Left atrial mechanical function after brief duration atrial fibrillation
J. Am. Coll. Cardiol., February 1, 1999; 33(2): 342 - 349.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. Valderrabano and B. N. Singh
Review : Electrophysiologic and Antiarrhythmic Effects of Propafenone: Focus on Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(3): 183 - 198.
[PDF]


Home page
CirculationHome page
C. Pandozi, L. Bianconi, M. Villani, G. Gentilucci, A. Castro, G. Altamura, A. P. Jesi, F. Lamberti, F. Ammirati, and M. Santini
Electrophysiological Characteristics of the Human Atria After Cardioversion of Persistent Atrial Fibrillation
Circulation, December 22, 1998; 98(25): 2860 - 2865.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N. S PETERS
Atrial fibrillation: towards an understanding of initiation, perpetuation, and specific treatment
Heart, December 1, 1998; 80(6): 533 - 534.
[Full Text]


Home page
CirculationHome page
S. Fareh, C. Villemaire, and S. Nattel
Importance of Refractoriness Heterogeneity in the Enhanced Vulnerability to Atrial Fibrillation Induction Caused by Tachycardia-Induced Atrial Electrical Remodeling
Circulation, November 17, 1998; 98(20): 2202 - 2209.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Janse, T. Opthof, and A. G. Kleber
Animal models of cardiac arrhythmias
Cardiovasc Res, July 1, 1998; 39(1): 165 - 177.
[Full Text] [PDF]


Home page
CirculationHome page
W.-C. Yu, S.-A. Chen, S.-H. Lee, C.-T. Tai, A.-N. Feng, B. I.-T. Kuo, Y.-A. Ding, and M.-S. Chang
Tachycardia-Induced Change of Atrial Refractory Period in Humans : Rate Dependency and Effects of Antiarrhythmic Drugs
Circulation, June 16, 1998; 97(23): 2331 - 2337.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. C. E. F. Wijffels, C. J. H. J. Kirchhof, R. Dorland, J. Power, and M. A. Allessie
Electrical Remodeling due to Atrial Fibrillation in Chronically Instrumented Conscious Goats : Roles of Neurohumoral Changes, Ischemia, Atrial Stretch, and High Rate of Electrical Activation
Circulation, November 18, 1997; 96(10): 3710 - 3720.
[Abstract] [Full Text]


Home page
CirculationHome page
E. G. Daoud, B. P. Knight, R. Weiss, M. Bahu, W. Paladino, R. Goyal, K. C. Man, S. A. Strickberger, and F. Morady
Effect of Verapamil and Procainamide on Atrial Fibrillation–Induced Electrical Remodeling in Humans
Circulation, September 2, 1997; 96(5): 1542 - 1550.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
D. R. Van Wagoner, A. L. Pond, P. M. McCarthy, J. S. Trimmer, and J. M. Nerbonne
Outward K+ Current Densities and Kv1.5 Expression Are Reduced in Chronic Human Atrial Fibrillation
Circ. Res., June 19, 1997; 80(6): 772 - 781.
[Abstract] [Full Text]


Home page
CirculationHome page
D. P. Zipes
Electrophysiological Remodeling of the Heart Owing to Rate
Circulation, April 1, 1997; 95(7): 1745 - 1748.
[Full Text]